Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
All Days
Friday
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
Filter Results:
-
+
EP02.04 - Early Stage Non-small Cell Lung Cancer - Systemic Therapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Early Stage Non-small Cell Lung Cancer - Systemic Therapy
-
+
EP02.04-001 - Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-Positive NSCLC: ALNEO Phase II Trial (GOIRC-01-2020)
Presenter: Alessandro Leonetti | Author(s): Roberta Minari, Luca Boni, Letizia Gnetti, Paola Bordi, Michela Verzè, Luca Ampollini, Francesco Gelsomino, Luca Toschi, Fabiana Cecere, Sara Pilotto, Giulio Metro, Francesco Passiglia, Diego Cortinovis, Fausto Barbieri, Giulia Pasello, Angelo Delmonte, Francesca Mazzoni, Emilio Bria, Domenico Galetta, Carlo Genova, Danilo Rocco, Hector Soto Parra, Alessandra Bearz, Maria Rita Migliorino, Andrea Camerini, Michele Tognetto, Marcello Tiseo- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-046 - Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO)
Presenter: Elio Gregory Pizzutilo | Author(s): Alberto Giuseppe Agostara, Sara Oresti, Diego Signorelli, Laura Giannetta, Stefano Stabile, Calogero Lauricella, Alessio Amatu, Marta Brambilla, Giuseppe Lo Russo, Claudia Proto, Laura Mazzeo, Teresa Beninato, Marco Siringo, Raffaele Giusti, Marco Filetti, Carlo Genova, Giulia Barletta, Marco Russano, Giuseppina Rita Di Fazio, Elena Tosoni, Giulio Metro, Sara Pilotto, Annamaria Carta, Francesca Mazzoni, Elisa Roca, Alain Jonathan Gelibter, Stefania Gori, Rossana Berardi, Giulio Cerea, Andrea Sartore-Bianchi, Salvatore Siena- Abstract
Loading... -
+
EP08.02-048 - Crizotinib in ROS1+NSCLC: Long-term OS Analysis in Patients with Brain Metastases Included in the Phase II METROS Trial
Presenter: Federico Cappuzzo | Author(s): Rita Chiari, Marcello Tiseo, Vincenzo Minotti, Filippo De Marinis, Angelo Delmonte, Maristella Bungaro, Diego Cortinovis, Domenico Galetta, Laura Bonanno, Antonio Chella, Cesare Gridelli, Alessandro Morabito, Francesco Grossi, Emilio Bria, Diana Giannarelli, Gabriella Fontanini, Gloria Borra, Stefania Gori, Francesca Mazzoni, Sara Pilotto, Lorenza Landi- Abstract
Loading...
-
+
EP14.01 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
-
+
EP14.01-006 - CeLEBrATE: Phase II trial of CarbopLatin, Etoposide, Bevacizumab and Atezolizumab in Patients with exTEnsive-Stage SCLC-GOIRC-01-2019
Presenter: Giuseppe Lamberti | Author(s): Elisa Andrini, Francesca Mazzoni, Ferdinando Riccardi, Andrea Bonetti, Alessandro Follador, Fabrizio Artioli, Carlo Genova, Fausto Barbier, Antonio Frassoldati, Matteo Brighenti, Ida Colantonio, Giulia Pasello, Corrado Ficorella, Saverio Cinieri, Marcello Tiseo, Francesco Gelsomino, Michele Tognetto, Karim Rihawi, Andrea Ardizzoni- Abstract
Loading...
